Collegium制药 COLL 深 沪
已收盘 10-31 16:00:00 美东时间
36.00
+0.350
+0.98%
华盛通- 最 高36.01
- 今 开35.47
- 成交量 25.84万股
- 最 低 35.36
- 昨 收 35.65
- 总市值 11.34亿
- 52周最高 39.95
- 市盈率 静 19.39
- 换手率 0.82%
- 52周最低 23.23
- 委 比 -43.91%
- 总股本 3150.21万
- 历史最高 42.2873
- 量 比 0.97
- 振 幅 1.82%
- 历史最低 7.37
- 每 手 1
- 风险率 3.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
Paris Hilton collaborates with Collegium Pharmaceutical to share her ADHD journey and encourage treatment. ADHD affects millions in the U.S., with many experiencing symptoms into adulthood. Hilton, diagnosed as a young adult, now advocates for awareness and appropriate treatment options. She uses JORNAY PM, a stimulant medication, and aims to reduce stigma around ADHD. The collaboration highlights the importance of discussing ADHD with healthcare...
10-29 12:00
美股大行评级 | 上调！苹果、亚马逊、Amkor Tech、Cadence、Confluent、卡特、通用动力等获多家上调目标价
今日重点评级关注：HC Wainwright & Co.：维持PepGen"买入"评级，目标价从12美元升至18美元；Piper Sandler：维持Prothena Corp"超配"评级，目标价从15美元升至36美元
10-29 09:25
Needham Reiterates Buy on Collegium Pharmaceutical, Maintains $46 Price Target
Needham analyst Serge Belanger reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and maintains $46 price target.
10-28 17:34
Pricol Limited Schedules Investor Conference Call for Q2/H1 FY26 Results
The latest update is out from Pricol Ltd. ( ($IN:PRICOLLTD) ). Pricol Limited h...
10-22 15:54
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
Collegium Pharmaceutical, Inc. announced poster presentations at AACAP (Oct 20-25 in Chicago) and NEI (Nov 6-9 in Colorado Springs) highlighting real-world data for Jornay PM, a methylphenidate HCl treatment for ADHD. The posters focus on optimal dosing in adolescents and adults and utilization in clinical practice. Jornay PM is a CII controlled substance with risks of abuse, addiction, and serious side effects, including heart problems and psych...
10-22 12:00
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) announced that its management team will ring the Nasdaq opening bell on October 14, 2025, at 9:30 a.m. ET to celebrate its 10-year anniversary as a publicly traded company. CEO Vikram Karnani highlighted the company's dedication to improving patient lives, its leadership in responsible pain management, and recent expansion into neuropsychiatry with the acquisition of Jornay PM® for ADHD, which is the ...
10-13 12:00
极光月狐｜泡泡玛特二季度业绩缓解市场焦虑，营收与利润双高
（来源：极光JIGUANG） 泡泡玛特主题乐园上半年客流量已超去年全年，目前正在进行扩张修缮新场景。在国内，品牌先后在成都SKP、北京SKP-S开设POP M...
09-28 18:00
Zevra Therapeutics rises amid takeover speculation
Zevra Therapeutics gained 7.5% amid some takeover speculation. Collegium Pharmaceuticals (COLL) was looking at purchasing Zevra Therapeutics, though it couldn't get the financing for a potential deal,...
09-25 22:37
THE BRAND HOUSE COLLECTIVE PROVIDES BUSINESS UPDATE
Bed Bath & Beyond Home Grand Opening Surpasses Expectations, Underscoring Brand Strength Kirkland's Home IP Sale Accelerates Conversions and Unlocks Wholesale Expansion Reports Q2 Fiscal 202...
09-16 19:00
CollPlant Expands the Distribution of its VergenixSTR Product in Europe
REHOVOT, Israel, Sept. 15, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies an...
09-15 19:00
